Allosteric interactions between GABAB1 subunits control orthosteric binding sites occupancy within GABAB oligomers

Gregory D. Stewart, Laëtitia Comps-Agrar, Lenea Blanc Nørskov-Lauritsen, Jean Philippe Pin, Julie Kniazeff

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

The GABAB receptor was the first G protein-coupled receptor identified as an obligate heterodimer. It is composed of two subunits, GABAB1 containing the agonist binding site and GABAB2 responsible for G protein activation. The GABAB receptor was found to associate into larger complexes through GABAB1-GABAB1 interactions, both in transfected cells and in brain membranes. Here we assessed the possible allosteric interactions between GABAB heterodimers by analyzing the effect of mutations located at the putative interface between the extracellular binding domains. These mutations decrease, but do not suppress, the Förster resonance energy transfer (FRET) signal measured between GABAB1 subunits. Further analysis of one of these mutations revealed an increase in G protein-coupling efficacy and in the maximal antagonist binding by approximately two-fold. Hypothesizing that a tetramer is an elementary unit within oligomers, additional FRET data using fluorescent ligands and tagged subunits suggest that adjacent binding sites within the GABAB oligomers are not simultaneously occupied. Our data show a strong negative effect between GABAB1 binding sites within GABAB oligomers. Accordingly, GABAB receptor assembly appears to limit receptor signaling to G proteins, a property that may offer novel regulatory mechanism for this important neuronal receptor. This article is part of the “Special Issue Dedicated to Norman G. Bowery”.

Original languageEnglish
Pages (from-to)92-101
Number of pages10
JournalNeuropharmacology
Volume136
DOIs
Publication statusPublished - 1 Jul 2018

Keywords

  • Allostery
  • G protein-coupled receptors
  • GABA
  • Oligomers

Cite this

Stewart, Gregory D. ; Comps-Agrar, Laëtitia ; Nørskov-Lauritsen, Lenea Blanc ; Pin, Jean Philippe ; Kniazeff, Julie. / Allosteric interactions between GABAB1 subunits control orthosteric binding sites occupancy within GABAB oligomers. In: Neuropharmacology. 2018 ; Vol. 136. pp. 92-101.
@article{a2ea81a881564bc9abd302f718dedf77,
title = "Allosteric interactions between GABAB1 subunits control orthosteric binding sites occupancy within GABAB oligomers",
abstract = "The GABAB receptor was the first G protein-coupled receptor identified as an obligate heterodimer. It is composed of two subunits, GABAB1 containing the agonist binding site and GABAB2 responsible for G protein activation. The GABAB receptor was found to associate into larger complexes through GABAB1-GABAB1 interactions, both in transfected cells and in brain membranes. Here we assessed the possible allosteric interactions between GABAB heterodimers by analyzing the effect of mutations located at the putative interface between the extracellular binding domains. These mutations decrease, but do not suppress, the F{\"o}rster resonance energy transfer (FRET) signal measured between GABAB1 subunits. Further analysis of one of these mutations revealed an increase in G protein-coupling efficacy and in the maximal antagonist binding by approximately two-fold. Hypothesizing that a tetramer is an elementary unit within oligomers, additional FRET data using fluorescent ligands and tagged subunits suggest that adjacent binding sites within the GABAB oligomers are not simultaneously occupied. Our data show a strong negative effect between GABAB1 binding sites within GABAB oligomers. Accordingly, GABAB receptor assembly appears to limit receptor signaling to G proteins, a property that may offer novel regulatory mechanism for this important neuronal receptor. This article is part of the “Special Issue Dedicated to Norman G. Bowery”.",
keywords = "Allostery, G protein-coupled receptors, GABA, Oligomers",
author = "Stewart, {Gregory D.} and La{\"e}titia Comps-Agrar and N{\o}rskov-Lauritsen, {Lenea Blanc} and Pin, {Jean Philippe} and Julie Kniazeff",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.neuropharm.2017.12.042",
language = "English",
volume = "136",
pages = "92--101",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier",

}

Allosteric interactions between GABAB1 subunits control orthosteric binding sites occupancy within GABAB oligomers. / Stewart, Gregory D.; Comps-Agrar, Laëtitia; Nørskov-Lauritsen, Lenea Blanc; Pin, Jean Philippe; Kniazeff, Julie.

In: Neuropharmacology, Vol. 136, 01.07.2018, p. 92-101.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Allosteric interactions between GABAB1 subunits control orthosteric binding sites occupancy within GABAB oligomers

AU - Stewart, Gregory D.

AU - Comps-Agrar, Laëtitia

AU - Nørskov-Lauritsen, Lenea Blanc

AU - Pin, Jean Philippe

AU - Kniazeff, Julie

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The GABAB receptor was the first G protein-coupled receptor identified as an obligate heterodimer. It is composed of two subunits, GABAB1 containing the agonist binding site and GABAB2 responsible for G protein activation. The GABAB receptor was found to associate into larger complexes through GABAB1-GABAB1 interactions, both in transfected cells and in brain membranes. Here we assessed the possible allosteric interactions between GABAB heterodimers by analyzing the effect of mutations located at the putative interface between the extracellular binding domains. These mutations decrease, but do not suppress, the Förster resonance energy transfer (FRET) signal measured between GABAB1 subunits. Further analysis of one of these mutations revealed an increase in G protein-coupling efficacy and in the maximal antagonist binding by approximately two-fold. Hypothesizing that a tetramer is an elementary unit within oligomers, additional FRET data using fluorescent ligands and tagged subunits suggest that adjacent binding sites within the GABAB oligomers are not simultaneously occupied. Our data show a strong negative effect between GABAB1 binding sites within GABAB oligomers. Accordingly, GABAB receptor assembly appears to limit receptor signaling to G proteins, a property that may offer novel regulatory mechanism for this important neuronal receptor. This article is part of the “Special Issue Dedicated to Norman G. Bowery”.

AB - The GABAB receptor was the first G protein-coupled receptor identified as an obligate heterodimer. It is composed of two subunits, GABAB1 containing the agonist binding site and GABAB2 responsible for G protein activation. The GABAB receptor was found to associate into larger complexes through GABAB1-GABAB1 interactions, both in transfected cells and in brain membranes. Here we assessed the possible allosteric interactions between GABAB heterodimers by analyzing the effect of mutations located at the putative interface between the extracellular binding domains. These mutations decrease, but do not suppress, the Förster resonance energy transfer (FRET) signal measured between GABAB1 subunits. Further analysis of one of these mutations revealed an increase in G protein-coupling efficacy and in the maximal antagonist binding by approximately two-fold. Hypothesizing that a tetramer is an elementary unit within oligomers, additional FRET data using fluorescent ligands and tagged subunits suggest that adjacent binding sites within the GABAB oligomers are not simultaneously occupied. Our data show a strong negative effect between GABAB1 binding sites within GABAB oligomers. Accordingly, GABAB receptor assembly appears to limit receptor signaling to G proteins, a property that may offer novel regulatory mechanism for this important neuronal receptor. This article is part of the “Special Issue Dedicated to Norman G. Bowery”.

KW - Allostery

KW - G protein-coupled receptors

KW - GABA

KW - Oligomers

UR - http://www.scopus.com/inward/record.url?scp=85040096589&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2017.12.042

DO - 10.1016/j.neuropharm.2017.12.042

M3 - Article

VL - 136

SP - 92

EP - 101

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -